You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指急彈逾550點 美團、友邦、安踏、李寧、匯控、碧服及藥明生物漲逾4%-9%
美國9月核心通脹年率續升溫至6.6%創逾40年高兼略超預期,利率期貨交易員押注聯儲局11月及12月均會再加息75點子,市場對局方續進取加息令經濟衰退憂慮升溫,美股三大指數昨晚早段在對息口敏感權重科網股及晶片股急挫主導急挫近1.9%-3.2%創近兩年至逾兩年低後,在技術性支持和趁低盤吸納推動,大市掉頭節節向上,30隻藍籌及標普11個主要板塊全部上揚,連日遭拋售的費城半導體指數也止跌回升2.9%,帶動納指、標指及道指分別倒升2.2%、2.6%及2.8%,道指跑贏最多倒升957點或3%。亞太股市今天全面報升,尤其是日經急彈903點或3.4%半日高收27,141,結束四連跌;澳股、韓股及台股也依次反彈1.8%-2.9%。 內地9月CPI及PPI按年升幅分別加快至2.8%及明顯放緩至0.9%均略低預期。受困於資金連日流出銀行體系的恆指終止六連跌,由11年低位曾回升至16,963,現報16,942,反彈553點或3.4%,總成交額453億元。此外,科指急彈4.1%報3,286,也結束六連跌。 藍籌股除中電(00002.HK)逆軟外,全部造好,升幅普遍逾1%-4%,其中新經濟股網易(09999.HK)、騰訊(00700.HK)、阿里(09988.HK)、百度(09888.HK)及美團(03690.HK)升逾3%-4%,分別高見114.1元、256.6元、76元、107.4元及154.4元。舜宇(02382.HK)及小米(01810.HK)升逾3%及4.5%,曾分別高見72.1元及8.94元。 醫藥股以中生製藥(01177.HK)及藥明生物(02269.HK)最強,股價急漲7%及9.3%,報3.93元及51.45元,後者股價三連升兼突破10天及20天線。 金融股以受惠鎊匯重越1.1關之上的匯控(00005.HK)升幅最大,股價隨倫敦急漲6%曾高見41.3元,重越10天線;非藍籌渣打(02888.HK)及保誠(02378.HK)也急漲5.8%及7.5%,分別報49.2元及80.3元。 三大藍籌保險股國壽(02628.HK)、平安(02318.HK)及友邦(01299.HK)升逾3.5%-4.5%,後者最強曾高見70.1元,現報69.8元,升4.7%。 四大藍籌內房升逾3%-5%,碧桂園(02007.HK)及龍湖(00960.HK)彈力最強,股價由昨天所創低位反彈曾高見1.47元及19.68元。碧服(06098.HK)彈逾6%曾高見9.72元。 內需股吉利(00175.HK)、比亞迪(01211.HK)、恆安(01044.HK)、安踏(02020.HK)及李寧(02331.HK)升逾3%-5%,後兩者跑贏分別報83.3元及59.3元,均漲逾半成。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account